Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Storytelling through food and feeling: Panda Express’ 2026 Lunar New Year program celebrates the holiday through heartfelt storytelling with its first-ever national animated short film “Wishes,” and...
Read More -
VILNIUS, Lithuania, Jan. 21, 2026 (GLOBE NEWSWIRE) -- As the tennis world turns its attention to the opening Grand Slam of the season, Australian Open 2026, WhiteBIT, Europe's largest...
Read More
-
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Semrush Holdings, Inc. (NYSE: SEMR)...
-
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- December 29, 2025 - Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of DigitalBridge Group,...
-
DEALSAGE, the cutting-edge institutional investment and M&A intelligence platform, announces expansion to new customer segments.
-
SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of OneStream, Inc. (NASDAQ: OS) breached...
-
Storytelling through food and feeling: Panda Express’ 2026 Lunar New Year program celebrates the holiday through heartfelt storytelling with its first-ever national animated short film “Wishes,” and...
-
Muck Rack's 2026 report, The State of AI in PR, examines how public relations professionals are using, governing and evaluating generative AI.
-
NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- StepStone Real Estate (SRE), the real estate arm of global private markets investment firm StepStone Group (Nasdaq: STEP), and Blue Moon Capital Partners...
-
Starstream Entertainment, Inc. Announces Completion of Acquisition of CityWalk E-Bike Inc. a China Focused Urban Mobility E-Bike Company
-
NAPC Defense (OTCID:BLIS) to attend the 2026 NASRO National School Safety Conference hold its 2026 annual shareholder meeting at the Peppermill Reno Resort
-
The Phase 1 clinical study of FAP-Exd (AVA6103) is anticipated to begin later in Q1 2026 LONDON and PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”,...